Literature DB >> 19553455

Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function.

Luna Abdallah1, Stephen J Bonasera, F Woodward Hopf, Laura O'Dell, Marco Giorgetti, Minke Jongsma, Scott Carra, Massimo Pierucci, Giuseppe Di Giovanni, Ennio Esposito, Loren H Parsons, Antonello Bonci, Laurence H Tecott.   

Abstract

The impact of serotonergic neurotransmission on brain dopaminergic pathways has substantial relevance to many neuropsychiatric disorders. A particularly prominent role has been ascribed to the inhibitory effects of serotonin 2C receptor (5-HT(2C)R) activation on physiology and behavior mediated by the mesolimbic dopaminergic pathway, particularly in the terminal region of the nucleus accumbens. The influence of this receptor subtype on functions mediated by the nigrostriatal dopaminergic pathway is less clear. Here we report that a null mutation eliminating expression of 5-HT(2C)Rs produces marked alterations in the activity and functional output of this pathway. 5-HT(2C)R mutant mice displayed increased activity of substantia nigra pars compacta (SNc) dopaminergic neurons, elevated baseline extracellular dopamine concentrations in the dorsal striatum (DSt), alterations in grooming behavior, and enhanced sensitivity to the stereotypic behavioral effects of d-amphetamine and GBR 12909. These psychostimulant responses occurred in the absence of phenotypic differences in drug-induced extracellular dopamine concentration, suggesting a phenotypic alteration in behavioral responses to released dopamine. This was further suggested by enhanced behavioral responses of mutant mice to the D(1) receptor agonist SKF 81297. Differences in DSt D(1) or D(2) receptor expression were not found, nor were differences in medium spiny neuron firing patterns or intrinsic membrane properties following dopamine stimulation. We conclude that 5-HT(2C)Rs regulate nigrostriatal dopaminergic activity and function both at SNc dopaminergic neurons and at a locus downstream of the DSt.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553455      PMCID: PMC3077993          DOI: 10.1523/JNEUROSCI.3905-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.

Authors:  G Di Giovanni; P De Deurwaerdére; M Di Mascio; V Di Matteo; E Esposito; U Spampinato
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence.

Authors:  J W Aldridge; K C Berridge
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

3.  Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  S H Fox; B Moser; J M Brotchie
Journal:  Exp Neurol       Date:  1998-05       Impact factor: 5.330

4.  D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance.

Authors:  S Hernández-López; J Bargas; D J Surmeier; A Reyes; E Galarraga
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

5.  Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro.

Authors:  I M Stanford; M G Lacey
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

6.  Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra.

Authors:  S Nedergaard; J P Bolam; S A Greenfield
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

7.  Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats.

Authors:  K Eberle-Wang; Z Mikeladze; K Uryu; M F Chesselet
Journal:  J Comp Neurol       Date:  1997-07-28       Impact factor: 3.215

8.  SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.

Authors:  V Di Matteo; G Di Giovanni; M Di Mascio; E Esposito
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

9.  Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.

Authors:  P De Deurwaerdère; U Spampinato
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

10.  Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens.

Authors:  V Di Matteo; G Di Giovanni; M Di Mascio; E Esposito
Journal:  Neuropharmacology       Date:  1998       Impact factor: 5.250

View more
  33 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

2.  Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.

Authors:  Nathan S Pentkowski; Felicia D Duke; Suzanne M Weber; Lara A Pockros; Andrew P Teer; Elizabeth C Hamilton; Kenneth J Thiel; Janet L Neisewander
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

3.  5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior.

Authors:  P V Strong; J P Christianson; A B Loughridge; J Amat; S F Maier; M Fleshner; B N Greenwood
Journal:  Neuroscience       Date:  2011-09-24       Impact factor: 3.590

4.  Reduced activity at the 5-HT(2C) receptor enhances reversal learning by decreasing the influence of previously non-rewarded associations.

Authors:  S R O Nilsson; T L Ripley; E M Somerville; P G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2012-05-29       Impact factor: 4.530

5.  A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.

Authors:  Clinton E Canal; Drake Morgan; Daniel Felsing; Krishnakanth Kondabolu; Neil E Rowland; Kimberly L Robertson; Rajeev Sakhuja; Raymond G Booth
Journal:  J Pharmacol Exp Ther       Date:  2014-02-21       Impact factor: 4.030

Review 6.  Learning From Animal Models of Obsessive-Compulsive Disorder.

Authors:  Patricia Monteiro; Guoping Feng
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

Review 7.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

Review 8.  Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders.

Authors:  Richard T O'Neil; Ronald B Emeson
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

9.  5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.

Authors:  Lara A Pockros; Nathan S Pentkowski; Sineadh M Conway; Teresa E Ullman; Kimberly R Zwick; Janet L Neisewander
Journal:  Synapse       Date:  2012-09-11       Impact factor: 2.562

10.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Authors:  Maria Talantova; Sara Sanz-Blasco; Xiaofei Zhang; Peng Xia; Mohd Waseem Akhtar; Shu-ichi Okamoto; Gustavo Dziewczapolski; Tomohiro Nakamura; Gang Cao; Alexander E Pratt; Yeon-Joo Kang; Shichun Tu; Elena Molokanova; Scott R McKercher; Samuel Andrew Hires; Hagit Sason; David G Stouffer; Matthew W Buczynski; James P Solomon; Sarah Michael; Evan T Powers; Jeffery W Kelly; Amanda Roberts; Gary Tong; Traci Fang-Newmeyer; James Parker; Emily A Holland; Dongxian Zhang; Nobuki Nakanishi; H-S Vincent Chen; Herman Wolosker; Yuqiang Wang; Loren H Parsons; Rajesh Ambasudhan; Eliezer Masliah; Stephen F Heinemann; Juan C Piña-Crespo; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.